Clinical Response in Rheumatoid Arthritis Patients with Anti-Infliximab Antibodies

被引:0
|
作者
Opris, Daniela [1 ]
Mazilu, Diana [1 ]
Ionescu, Ruxandra [1 ]
机构
[1] Carol Davila Univ MEd, Sfanta Maria Hosp, Dept Rheumatol, Bucharest, Romania
关键词
Rheumatoid arthritis; infliximab; immunogenicity; methotrexate;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P-132
引用
收藏
页码:S40 / S41
页数:2
相关论文
共 50 条
  • [21] Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD
    Steenholdt, C.
    Brynskov, J.
    Bendtzen, K.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (05) : 499 - 500
  • [22] Commentary: detection of infliximab levels and anti-infliximab antibodies
    Seow, C. H.
    Panaccione, R.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (01) : 153 - 154
  • [23] ESTABLISHING CUT-OFF OF INFLIXIMAB AND ANTI-INFLIXIMAB ANTIBODY LEVELS USING A COMMERCIAL ELISA IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Hernandez, D.
    De la Torre, I.
    Martinez, L.
    Nieto, J.
    Llinares, F.
    Rosas, J.
    Gonzalez, C.
    Monteagudo, I.
    Lopez-Longo, J.
    Montoro, M.
    Carreno, L.
    Valor, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 237 - 237
  • [24] CLINICAL RELEVANCE OF MEASURING FREE VERSUS TOTAL ANTI-INFLIXIMAB ANTIBODIES IN PATIENTS WITH SPONDYLOARTHRITIS
    Ruiz del Agua, A.
    Pascual, J.
    Torres, N.
    Pascual-Salcedo, D.
    Martinez, A.
    Jurado, T.
    Plasencia, C.
    Balsa, A.
    Ruiz-Arguello, B.
    Maguregui, A.
    Ametzazurra, A.
    Martinez, A.
    Nagore, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1128 - 1129
  • [25] Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formation
    de Vries, Mirjam K.
    Wolbink, Gerrit Jan
    Stapel, Steven O.
    de Vrieze, Henk
    van denderen, J. Christiaan
    Dijkmans, Ben A. C.
    Aarden, Lucien A.
    van der Horst-Bruinsma, Irene E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (09) : 1252 - 1254
  • [26] Significance of low level infliximab in the absence of anti-infliximab antibodies
    Bella Ungar
    Adi Anafy
    Henit Yanai
    Yulia Ron
    Miri Yavzori
    Orit Picard
    Ella Fudim
    Ronen Loebstein
    Uri Kopylov
    Yehuda Chowers
    Iris Dotan
    Rami Eliakim
    Shomron Ben-Horin
    [J]. World Journal of Gastroenterology, 2015, (06) : 1907 - 1914
  • [27] PRESENCE OF ANTIBODIES TO ADALIMUMAB AND INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL REMISSION
    Eng, G.
    Fana, V.
    Omerovic, E.
    Hojsgaard, P.
    Lindegaard, H. M.
    Jensen, E. K.
    Bouchelouche, P. N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 230 - 230
  • [28] ISOTYPE CHARACTERIZATION OF ANTI-INFLIXIMAB ANTIBODIES IN PEDIATRIC PATIENTS WITH RHEUMATIC DISEASES TREATED WITH INFLIXIMAB
    Kosmac, M.
    Toplak, N.
    Simonini, G.
    Cimaz, R.
    Serbec, V. Curin
    Avcin, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 255 - 255
  • [29] Association of serum anti-centromere protein F antibodies with clinical response to infliximab in patients with rheumatoid arthritis: A prospective study
    Lourido, Lucia
    Ruiz-Romero, Cristina
    Picchi, Flor
    Diz-Rosales, Naomi
    Vilaboa-Galan, Sergio
    Fernandez-Lopez, Carlos
    Pinto Tasende, Jose Antonio
    Perez-Pampin, Eva
    Regueiro, Cristina
    Mera-Varela, Antonio
    Gonzalez, Antonio
    Hambardzumyan, Karen
    Saevarsdottir, Saedis
    Nilsson, Peter
    Blanco, Francisco J.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (05) : 1101 - 1108
  • [30] Anti-Infliximab Antibodies in Routine Clinical Practice - Is It Worth to Assess Them?
    Lukas, Milan
    Malickova, Karin
    Bortlik, Martin
    Duricova, Dana
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A679 - A679